Summary

US Medical Biomimetics Market is valued approximately USD 9.58 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.86 % over the forecast period 2024-2032. Medical biomimetics combines biology, engineering, and materials science to develop novel approaches to medical problems. Researchers emulate biological processes, structures, and systems to create medical technologies that mimic nature's efficiency and adaptability. Medical biomimetics finds applications in prosthetics, tissue engineering, drug delivery, surgical tools, imaging, and beyond. This interdisciplinary approach promises to revolutionize healthcare by providing safer, more effective, and sustainable treatments and interventions. Moreover, the biomimetic approaches are contributing to the advancement of personalized medicine, where treatments and interventions are tailored to individual patients based on their unique biological characteristics and needs. This includes the development of biomimetic models for drug screening and disease modeling.

The growing preference for minimally invasive surgical techniques is driving the demand for biomimetic surgical instruments, implants, and robotic systems. Biomimetic designs enable enhanced maneuverability, precision, and tissue compatibility, facilitating minimally invasive procedures and improving patient outcomes. Additionally, other factors support the market growth are growing demand for advanced medical technologies, increasing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and cancer, advances in biomaterials science, biotechnology, and tissue engineering, and growing shift towards personalized and precision medicine approaches. However, stringent regulatory framework, and high development costs are expected to hinder the market growth during the forecast period 2024-2032.

Major market player included in this report are:
Stryker Corporation
Abbott Laboratories
SynTouch Inc.
Vandstrom, Inc.
Biomimetics Technologies Inc.
Keystone Dental Group
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Disease Type
Ophthalmology
Cardiovascular
Orthopedic
Dental
Others

By Application
Wound Healing
Tissue Engineering
Drug Delivery
Others


Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. US Medical Biomimetics Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. US Medical Biomimetics Market Size & Forecast (2022- 2032)
2.2. Segmental Summary
2.2.1. By Disease Type
2.2.2. By Application
2.3. Key Trends
2.4. Recession Impact
2.5. Analyst Recommendation & Conclusion
Chapter 3. US Medical Biomimetics Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. US Medical Biomimetics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. US Medical Biomimetics Market Size & Forecasts by Disease Type 2022-2032
5.1. Ophthalmology
5.2. Cardiovascular
5.3. Orthopedic
5.4. Dental
5.5. Others
Chapter 6. US Medical Biomimetics Market Size & Forecasts by Application 2022-2032
6.1. Wound Healing
6.2. Tissue Engineering
6.3. Drug Delivery
6.4. Others
Chapter 7. Competitive Intelligence
7.1. Key Company SWOT Analysis
7.1.1. Company 1
7.1.2. Company 2
7.1.3. Company 3
7.2. Top Market Strategies
7.3. Company Profiles
7.3.1. Stryker Corporation
7.3.1.1. Key Information
7.3.1.2. Overview
7.3.1.3. Financial (Subject to Data Availability)
7.3.1.4. Product Summary
7.3.1.5. Market Strategies
7.3.2. Abbott Laboratories
7.3.3. SynTouch Inc.
7.3.4. Vandstrom, Inc.
7.3.5. Biomimetics Technologies Inc.
7.3.6. Keystone Dental Group
7.3.7. Company 7
7.3.8. Company 8
7.3.9. Company 9
7.3.10. Company 10
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes